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Objectives. This study sought to examine the management and
subsequent outcomes of patients with a prehospital electrocardio-
gram (ECG) in a large, voluntary registry of myocardial infarc-
tion.
Background. The prehospital ECG has been proposed as a
means of rapidly identifying patients with acute myocardial
infarction who might be eligible for reperfusion therapy.
Methods. The characteristics and outcomes of patients with a
prehospital ECG were compared with those without a prehospital
ECG in the National Registry of Myocardial Infarction 2 data
base. Included in the analysis were those patients who presented
to the hospital within 12 h of an acute myocardial infarction.
Excluded were patients with an in-hospital infarction, transferred-in
referrals and self-transported patients.
Results. Prehospital ECGs were obtained in 3,768 (5%) of
66,995 National Registry of Myocardial Infarction 2 patients
meeting study criteria. Median time from myocardial infarction
symptom onset until hospital arrival was longer among those
having a prehospital ECG (152 vs. 91 min, p < 0.001). However,
once in the hospital, the prehospital ECG group experienced a
shorter median time to the initiation of either thrombolysis (30 vs.
40 min, p < 0.001) or primary angioplasty (92 vs. 115 min, p <
0.001). The prehospital ECG group was more likely to receive
thrombolytic therapy (43% vs. 37%, p < 0.001) and to undergo
primary angioplasty (11% vs. 7%, p < 0.001). Also, the prehospital
ECG group was more likely to undergo coronary arteriography
(55% vs. 40%, p < 0.001), angioplasty (24% vs. 16%, p < 0.001) or
bypass surgery (10% vs. 6%, p < 0.001). The in-hospital mortality
rate was 8% in patients with a prehospital ECG and 12% in those
without a prehospital ECG (p < 0.001). After adjusting for
baseline covariates utilizing multiple logistic regression analysis,
this mortality difference remained statistically significant (odds
ratio 0.83, 95% confidence interval 0.71 to 0.96, p 5 0.01).
Conclusions. The prehospital ECG is infrequently utilized for
diagnosing myocardial infarction, and among patients with a
prehospital ECG, is associated with a longer time from symptom
onset to hospital arrival. Despite these shortcomings, the prehos-
pital ECG is a test that may potentially influence the management
of patients with acute myocardial infarction through wider, faster
in-hospital utilization of reperfusion strategies and greater usage
of invasive procedures, factors that may possibly reduce short-
term mortality. Efforts to implement the prehospital ECG more
widely and more rapidly may be indicated.
(J Am Coll Cardiol 1997;29:498–505)
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With the recognition that as many as 1.25 million people will
experience an acute myocardial infarction, resulting in almost
500,000 deaths each year in the United States (1), there is a
paradigm that is clearly shifting toward earlier and more aggres-
sive treatment. By advancing health care delivery through the
promotion of government-sponsored national task force recom-
mendations (2), community-based educational campaigns and the
development of chest pain centers throughout the country, the
recent emphasis has been on the early recognition, identification
and treatment of acute myocardial infarction.
It is clear that reducing the time to reperfusion therapy in
patients with acute myocardial infarction leads to improved
survival. The Global Utilization of Streptokinase and t-PA for
Occluded Coronary Arteries (GUSTO) angiographic substudy
(3) has shown the critical importance of Thrombolysis in
Myocardial Infarction (TIMI) grade 3 flow at 90 min. The
Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto
Miocardico (GISSI) trial (4) and other thrombolytic studies
(3,5–8), showed a clear inverse relation between time to
delivery of thrombolytic therapy and percent myocardial sal-
vage or survival. Thrombolytic therapy within #1 h after
symptom onset was associated with the greatest benefit. Pre-
hospital thrombolysis has been recently evaluated as a means
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of decreasing chest pain symptom to treatment times (8–22).
However, the results from three of the largest prehospital
thrombolytic trials (8–10) suggest that the critical issue is not
where but when therapy is initiated (23).
Investigators have begun to examine the utility of the
prehospital ECG as a means of rapidly identifying patients
with acute myocardial infarction who are eligible for acute
reperfusion therapy and thereby reducing in-hospital treat-
ment times. However, to date, limited studies involving only a
small number of patients have suggested that the prehospital
ECG may decrease in-hospital thrombolytic therapy adminis-
tration times (24–28). Performance of prehospital ECGs is one
variable being collected in the ongoing National Registry of
Myocardial Infarction 2, a voluntary data base recording
presenting characteristics, treatment and in-hospital outcome
of patients with acute myocardial infarction at .25% of all
acute care hospitals in the United States. The purpose of the
present report is to analyze the characteristics and outcomes of
patients with a prehospital ECG in this large registry data base.
Methods
Patient population. The National Registry of Myocardial
Infarction is a multicenter, voluntary data base designed to
collect, analyze and report cross-sectional data on consecutive
patients with myocardial infarction enrolled at participating
hospitals (29). This registry is supported by Genentech, Inc.
(South San Francisco, California). Data from each enrolled
patient are entered onto a two-page case report form and
forwarded to ClinTrials Research, Inc. (Lexington, Kentucky).
Before entry into the national data base, all data forms are
subjected to internal consistency and data range checking. Partic-
ipating hospitals are then furnished quarterly tabulations of their
individual data as well as parallel quarterly tabulations of state
and national results. Strict confidentiality of the individual patient
and each respective registry hospital are maintained.
This study reports findings from 1,388 hospitals that enrolled
275,046 patients with acute myocardial infarction into the Na-
tional Registry of Myocardial Infarction 2 from June 1994 to
April 1996.We restricted our analysis to those patients whose first
12-lead ECG was obtained within 12 h of initial myocardial
infarction symptoms. Patients with in-hospital infarctions, those
transferred in from other hospitals and self (nonambulance)-
transported patients were excluded from this analysis.
Study variables. The study population was classified into
two groups: those with a prehospital ECG and those without a
prehospital ECG. A prehospital ECG was defined as any ECG
obtained before hospital arrival. The data collection process did
not distinguish between prehospital ECGs obtained by paramed-
ics in the field versus those obtained in physician offices.
Patients with a prehospital ECG were compared with those
without a prehospital ECG according to the following vari-
ables: baseline characteristics, median time interval from myo-
cardial infarction symptom onset to first ECG and hospital
presentation; median time intervals from hospital arrival to
reperfusion therapy; proportion and modality of acute reper-
fusion therapy utilized; in-hospital interventions; and clinical
events, including mortality. Myocardial infarction symptom
onset referred to the onset of cardiac ischemic symptoms related
to the acute event and was defined by chest pain or pressure, arm
or jaw pain, dyspnea, nausea or vomiting, syncope or cardiac
arrest. For patients with stuttering symptoms, onset of infarction
was recorded when symptoms became constant in quality or
intensity. Also, in a separate analysis, hospital characteristics of
participating hospitals contributing at least one patient with a
prehospital ECG to the registry were compared with those not
enrolling any patients with a prehospital ECG.
Statistical methods. Differences between the prehospital
ECG and no prehospital ECG groups were assessed by the
chi-square test for categoric variables, the Wilcoxon rank sum
test for time intervals and the t test for all other continuous
variables. Multiple logistic regression analysis was utilized to
ascertain variables independently predictive of mortality in the
study population. All statistical analyses were performed with
SAS 6.06 statistical package programs (SAS Institute). This
report is based on information processed by the central data
collections center as of April 30, 1996.
Results
Patient characteristics (Tables 1 and 2). Of the 70,763
patients satisfying the study criteria, a prehospital ECG was
Abbreviations and Acronyms
CI 5 confidence interval
ECG 5 electrocardiogram, electrocardiographic
OR 5 odds ratio
Table 1. Patient Characteristics
PH-ECG
(n 5 3,768)
No PH-ECG
(n 5 66,995)
p
Value
General
Mean age (yr) 65 68 , 0.001
Mean weight (lb) 178 172 , 0.001
% white 88 87 0.23
% male 69 59 , 0.001
Previous history of (%)
Myocardial infarction 19 28 , 0.001
Angina 16 19 , 0.001
Congestive heart failure 7 15 , 0.001
Coronary angioplasty 6 8 , 0.001
Coronary bypass surgery 9 11 , 0.001
Previous cardiac risk factors (%)
Diabetes mellitus 20 25 , 0.001
Hypertension 47 48 0.31
Smoking 30 27 , 0.001
Family history of CAD 32 26 , 0.001
Hypercholesterolemia 27 22 , 0.001
CAD 5 coronary artery disease; PH-ECG 5 prehospital electrocardiogram.
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obtained in only 3,768 (5%). Those patients with a prehospital
ECG were slightly younger and were predominantly male, with
a lower likelihood of significant cardiac history, such as previ-
ous myocardial infarction, angina, heart failure, coronary
angioplasty and bypass surgery. They also had a trend toward
less heart failure despite a slightly higher frequency of anterior
infarction.
Time intervals: pain onset until ECG, hospital arrival and
reperfusion intervention (Fig. 1 and 2). The median time
interval from symptom onset to acquisition of the first ECG
was significantly longer in the prehospital ECG group than in
the no prehospital ECG group (120 vs. 108 min). In addition,
the interval from symptom onset to hospital arrival was longer
in the prehospital ECG group (152 vs. 91 min). However, for
patients receiving reperfusion therapy, the interval from hos-
pital arrival to treatment was significantly shorter in the
prehospital ECG group (Fig. 2): thrombolytic therapy (median
time 30 vs. 40 min) and primary angioplasty (median time 92
vs. 115 min). Finally, among those who received either intra-
venous thrombolytic therapy or primary angioplasty, the over-
all time from symptom onset to reperfusion therapy was longer
in the prehospital ECG group for both thrombolytic therapy
(median time 175 vs. 136 min) or primary angioplasty (median
time 245 vs. 215 min).
Acute reperfusion therapy. In the prehospital ECG group,
the proportion of patients who received reperfusion therapy
was significantly greater (Fig. 3): thrombolytic therapy (43%
vs. 37%) and primary angioplasty (11% vs. 7%). Conversely, if
a prehospital ECG was not obtained, the patient was more
likely not to receive acute reperfusion therapy (56% vs. 46%).
In a subgroup analysis, when only patients whose first ECG
revealed ST segment elevation or left bundle branch were
considered, the overall proportion of patients who received
acute reperfusion therapy (thrombolytic therapy or primary
angioplasty) was still greater in the prehospital ECG group
(71% vs. 65%, p , 0.001).
Thrombolytic therapy (Table 3). The physician ordering
thrombolytic therapy in the no prehospital ECG group was
most often the emergency department physician, whereas in
the prehospital ECG group, thrombolytic therapy was ordered
Figure 1. Comparison of time intervals from symptom onset until first
ECG and hospital (Hosp) arrival between prehospital (PH) ECG and
no prehospital ECG groups. Median time to first ECG and hospital
arrival were significantly longer in the prehospital ECG group.
Figure 2. Comparison of time intervals between hospital arrival to
treatment for patients having thrombolytic therapy (Lytic Rx) and
primary angioplasty. Median times to treatment were significantly
shorter in patients with a prehospital (PH) ECG. PTCA 5 percuta-
neous transluminal coronary angioplasty.
Figure 3. Use of acute reperfusion therapy in all study patients: Both
intravenous thrombolytic therapy and primary angioplasty were more
commonly utilized in the prehospital ECG group. Rx 5 treatment;
other abbreviations as in Figure 2.
Table 2. Clinical Presentation
PH-ECG
(n 5 3,760)
No PH-ECG
(n 5 66,708) p Value
Mean systolic BP (mm Hg) 138 137 0.22
Mean diastolic BP (mm Hg) 81 79 0.001
Mean pulse (min21) 81 85 , 0.001
Killip class (%) 0.14
I (no heart failure) 85 70
II (rales) 10 17
III (pulmonary edema) 4 10
IV (cardiogenic shock) 2 3
1st 12-lead ECG (%)
ST segment elevation 63 54 , 0.001
ST segment elevation or left
bundle branch block
65 59 , 0.001
Anterior infarct location (%) 32 30 0.003
BP 5 blood pressure; PH-ECG 5 prehospital electrocardiogram.
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with equal frequency between the emergency department
physician and the cardiologist. The site of administration of
thrombolytic therapy was usually the emergency department in
both groups, but patients with a prehospital ECG were some-
what more likely to receive thrombolytic therapy in the inten-
sive care unit or catheterization laboratory. Prehospital throm-
bolytic therapy was administered in only 0.10% (n 5 70) of all
study patients.
In-hospital interventions (Fig. 4). In the prehospital ECG
group, patients were significantly more likely to undergo
coronary arteriography (55% vs. 40%), coronary angioplasty
(24% vs. 16%) and coronary bypass surgery (10% vs. 6%).
Hospital morbidity and mortality (Table 4, Figure 5).
There were no significant differences in recurrent ischemia or
recurrent infarction between the two groups, but there were
fewer episodes of heart failure and hypotension requiring drug
treatment in the prehospital ECG group. In addition, ejection
fraction was higher and freedom from adverse events more
common in the prehospital ECG group.
In the prehospital ECG group, the unadjusted hospital
mortality for the overall population was significantly lower (8%
vs. 12%) and for each of the subgroups: intravenous thrombo-
lytic therapy (5% vs. 7%), primary angioplasty (4% vs. 9%) and
no reperfusion therapy (12% vs. 16%). To determine whether
the prehospital ECG might be an independent predictor
associated with lower mortality, multivariate logistic analysis
was performed, adjusting for baseline covariates. Variables
included in the model are shown in Figure 5. Prehospital ECG
was found to be an independent predictor of lower overall
mortality (odds ratio [OR] 0.83, 95% confidence interval [CI]
0.71 to 0.96, p 5 0.01).
Hospital mortality adjusted for symptom onset to first
ECG. Because of the disparity in time interval from symptom
onset to first ECG (Fig. 1), a secondary analysis was performed
assessing mortality as a function of time to first ECG in the
prehospital and no prehospital ECG groups. Hospital mortal-
ity differed between the two groups only among patients having
their first ECG within 3 h of symptom onset and was lower in
the prehospital ECG group (OR 0.80, 95% CI 0.65 to 0.99, p5
0.04). The relative benefit of prehospital ECG was even
stronger among those receiving their first ECG within 1 h of
symptom onset (OR 0.65, 95% CI 0.47 to 0.89, p 5 0.007).
Hospital characteristics (Table 5). Hospitals in communi-
ties with prehospital ECG capability, as defined by the hospital
enrolling at least one patient with a prehospital ECG during
the study interval, tended to have a larger mean number of
staffed beds and emergency department visits per year and
were more likely to have coronary arteriography, coronary
angioplasty and cardiac surgery capabilities than hospitals not
receiving patients with a prehospital ECG. Although prehos-
pital ECGs were obtained in only a minority of patients,.75%
of patients (55,290 of 70,763) analyzed in this report presented
to hospitals in communities with prehospital ECG capability.
Figure 4. In-hospital interventions: coronary artery bypass graft sur-
gery (CABG), coronary arteriography (CATH) and percutaneous
transluminal coronary angioplasty (PTCA). Patients (Pts) with prehos-
pital (PH) ECGs had more subsequent invasive cardiac procedures
performed in the hospital.
Table 3. Thrombolytic Therapy
PH-ECG
(n 5 3,768)
No PH-ECG
(n 5 66,995) p Value
Thrombolytic Rx [no. (%)] 1,595 (42%) 24,964 (37%) , 0.001
Ordered by (%) 0.18
Emergency MD 46 59
Cardiologist 44 33
Other 10 8
Site initiated (%) 0.04
Emergency room 78 91
Intensive care unit 20 9
Cath lab/other 1.8 0.2
lab 5 laboratory; MD 5 medical doctor; PH-ECG 5 prehospital electro-
cardiogram; Rx 5 treatment.
Table 4. Clinical End Points
PH-ECG
(n 5 3,768)
No PH-ECG
(n 5 66,995) p Value
Recurrent ischemia (%) 14 13 0.73
Recurrent infarction (%) 3 3 0.06
CHF requiring drug Rx (%) 12 18 , 0.001
Hypotension requiring
intervention (%)
15 19 , 0.001
Cardiogenic shock (%) 5 7 , 0.001
Stroke (%) 1 1 0.38
Major bleeding (%) 3 2 0.29
Free of adverse outcome (%)* 55 48 , 0.001
Ejection fraction (%) 49 46 , 0.001
(n 5 2,043) (n 5 33,664)
Mean hospital stay (days) 6.1 6.4 0.001
Hospital mortality (%)
All patients (n 5 44,434) 8 12 , 0.001
IV lytic (n 5 17,028) 5 7 0.01
Primary PTCA (n 5 2,895) 4 9 ,0.001
No reperfusion (n 5 24,238) 12 16 , 0.001
*No in-hospital clinical events, stroke, major bleeding or death. CHF 5
congestive heart failure; IV lytic 5 intravenous thrombolytic therapy; PTCA 5
percutaneous transluminal coronary angioplasty; other abbreviations as in
Table 3.
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Discussion
This report, to our knowledge the largest observational
study of prehospital ECG to date, shows that the prehospital
ECG is infrequently obtained and was acquired in only 5% of
70,763 selected patients with acute myocardial infarction ad-
mitted to participating hospitals in the National Registry of
Myocardial Infarction 2 data base from 1994 to 1996. Despite
its infrequent application, the prehospital ECG was associated
with wider usage of both thrombolytic therapy and primary
angioplasty; faster in-hospital utilization of such resources;
higher usage of invasive procedures, including coronary arte-
riography and revascularization procedures; and a trend to-
ward lower mortality, even after adjustment for baseline
covariates.
Potential advantages of prehospital ECG. In theory, the
prehospital ECG has the potential of rearranging the four
major points (the “Four D’s”) where delay can occur in the
emergency department (2): arrival and triage (Door); obtain-
ing an ECG (Data); decision to use intravenous thrombolytic
therapy or alternative reperfusion interventions (Decision);
and initiating thrombolytic therapy (Drug). In bypassing “the
door” as a barrier to early identification of acute myocardial
infarction, the prehospital ECG can be used for prehospital
notification that a patient with a myocardial infarction is en
route; hospital resources can then be mobilized immediately to
rapidly triage the patient for reperfusion therapy on arrival.
Early cardiology consultation may be obtained for difficult
ECG interpretations, perhaps even before the patient arrives
at the emergency department. These scenarios may lead to
better patient outcomes.
The prehospital ECG may also be a useful tool to triage
patients to hospital facilities better equipped to manage acute
myocardial infarction. The surgical community has shown a
dramatic improvement in patient outcome after designating
hospitals capable of receiving patients for different levels of
Figure 5. Independent predictors of hospital mortality
were assessed by multiple logistic regression analysis.
Shown are odds ratios and 95% confidence intervals.
Performance of prehospital ECG was associated with
decreased mortality. CABG 5 coronary artery bypass
graft surgery; CHF 5 congestive heart failure; DM 5
diabetes mellitus; HTN 5 hypertension; IV lytic 5 intra-
venous thrombolytic; MI 5 myocardial infarction; PTCA 5
percutaneous transluminal coronary angioplasty; Rx5 treat-
ment.
Table 5. Hospital Characteristics*
PH-ECG
Capability
No PH-ECG
Capability
p
Value
No. of hospitals 828 573
Total patients meeting 55,290 15,473
study criteria [no. (%)] (78%) (22%)
Mean no. of staffed beds 287 213 , 0.001
Mean no. of ED visits/yr 33,508 27,177 0.001
EMS provider (%) 99 99 0.65
Cath capability (%) 79 61 , 0.001
PTCA capability (%) 54 34 , 0.001
CABG capability (%) 46 27 , 0.001
*These data were obtained from a survey completed by each hospital before
entry into the National Registry of Myocardial Infarction; prehospital electro-
cardiogram (ECG) capability is defined by the hospital enrolling at least one
patient with a prehospital ECG during the study interval. CABG 5 coronary
artery bypass graft; Cath 5 coronary catheterization; ED 5 emergency depart-
ment; EMS 5 emergency medical services; other abbreviations as in Tables 3
and 4.
502 CANTO ET AL. JACC Vol. 29, No. 3
PREHOSPITAL ECG IN AMI March 1, 1997:498–505
trauma care (30–32). The same critierion may be applied to
the patient with an acute myocardial infarction, where rapid
and appropriate skilled intervention is of significant impor-
tance. Although cardiac patients today are transported to the
nearest hospital, the future standard of care may mandate
preference (when choice exists) for facilities best equipped to
provide state of the art care. The prehospital ECG may
potentially be the tool with which this concept is implemented.
Time to hospital arrival. We anticipated that the prehos-
pital ECG group would receive their first ECG sooner after
symptoms onset than the no prehospital ECG group, but this
was not the case. Surprisingly, the prehospital ECG group had
a significantly longer time from symptoms onset to hospital
presentation (152 vs. 91 min). Possible explanations may
include the following: 1) a procedural time delay in obtaining
the prehospital ECG. Data from three previous studies
(25,26,33) reveal that obtaining the prehospital ECG may add
only 5 to 10 min to treatment times. However, although
obtained rapidly, the prehospital ECG may trigger other
delaying maneuvers in the field, such as starting another
intravenous line, drawing up medications or carrying out other
orders given by the accepting hospital. In the future, it may still
be possible to obtain a prehospital ECG and transport patients
faster, with greater paramedic awareness of this potential
pitfall. Additionally, the prehospital ECG may have been
obtained by staff at private physicians’ offices rather than by
paramedics in the field, adding substantially to prehospital
delay. 2) The baseline characteristics of the two groups were
different, which may affect the speed at which patients are
likely to call for help after infarct onset. In this data base, the
prehospital ECG group had more patients without a previous
cardiac history. Although not proven, such patients may con-
ceivably procrastinate longer before seeking medical attention
because they are less likely to recognize the significance of
myocardial infarction symptoms. 3) A selection bias may have
led to prehospital ECGs being obtained in patients living
larger distances from the nearest hospital. 4) A selection bias
may have led to greater transport of patients with ECG
evidence of an acute myocardial infarction to hospitals recog-
nized for acute myocardial infarction care. Such hospitals may
be more distant than the nearest hospital and therefore
increase transport times.
Given the unexpected longer presenting time intervals seen
in the prehospital ECG group, a subsidiary analysis was
performed to further examine the impact of stratifying the data
base by onset of symptoms to first ECG time interval. Our
results show that obtaining a prehospital ECG within 3 h of
symptom onset may favorably influence the management of
the patient with an acute myocardial infarction and potentially
improve survival. If patients can activate the emergency med-
ical service in an expedient manner, this may allow an oppor-
tunity for the prehospital ECG to influence outcome through
wider, faster implementation of reperfusion therapy and
thereby allow greater salvage of myocardium at risk. In con-
trast, there may be no additional benefit in obtaining a
prehospital ECG if the patient presents much later than 3 h.
Presumably, as more myocardium is lost over time, the incre-
mental value of performing a prehospital ECG may also be
diminished.
Time to reperfusion. Although the prehospital ECG group
presented much later to the hospital, acute reperfusion therapy
was utilized to a greater extent, and median in-hospital interval
times to reperfusion therapy were shorter. In-hospital treat-
ment times were less in both the intravenous thrombolytic and
primary angioplasty-treated groups, but the disparity was much
larger in the latter group. This finding of reduced in-hospital
treatment times seems reasonable because many can envision
scenarios where the emergency room, aware of the prehospital
ECG findings, is ready to receive the patient with a myocardial
infarction and administer thrombolytic therapy (so-called
“thrombolytic alertness”), or the catheterization laboratory
team is prepared to move directly to emergency coronary
arteriography and primary angioplasty.
The greater utilization of reperfusion therapy in the pre-
hospital ECG group may be attributed to a higher proportion
of patients presenting with ST segment elevation or left bundle
branch block on a first ECG as well as a higher proportion of
prehospital ECG group patients with an anterior infarction.
However, in a separate subgroup analysis that examined only
patients with ECG evidence of ST segment elevation or left
bundle branch block, the prehospital ECG group still had an
overall higher proportion of patients undergoing acute reper-
fusion therapy. Other plausible explanations may include
greater cardiology input on the use of thrombolytic therapy or
primary angioplasty in the prehospital ECG group or patients
being selectively transported to medical facilities more familiar
with indications for reperfusion therapy, once acute myocar-
dial infarction is identified by prehospital ECG testing.
Limitations of the study. Limitations inherent in the Na-
tional Registry of Myocardial Infarction data base have been
described previously (29). There is the potential for noncon-
secutive patient enrollment, lack of independent on-site vali-
dation of data forms and the fact that registry hospitals may
not be representative of all U.S. hospitals. However, the
massive size of the registry, its widespread geographical dis-
persion throughout the United States and its mandatory
internal data consistency checks add to its credibility. An
additional limitation unique to this study is the inability of the
data collection process to distinguish between prehospital
ECGs obtained by emergency medical services and those
obtained in private physicians’ offices. If many of the prehos-
pital ECGs were obtained in physicians’ offices, this may
explain the unexpected longer median times from myocardial
infarction symptom onset to acute reperfusion therapy. In
addition, the registry did not include details of equipment
utilized or the experience and training of personnel obtaining
prehospital ECGs. Although such information might have
provided useful insights, its absence does not compromise the
actual findings of the study. Also, this report represents an
observational rather than a randomized analysis. Although a
randomized trial is generally better for assessing new diagnos-
tic tools, its use in the prehospital evaluation of outcome may
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be limited by the Hawthorne effect (34,35). This phenomenon
recognizes that study personnel’s behavior may be influenced
by the awareness that they are being closely observed in a trial.
This limitation of randomized trials is unlikely to affect large
registry populations like the National Registry of Myocardial
Infarction 2 data base, which reflects “real-world” national
practice patterns. Finally, because this registry represented
only patients with an actual myocardial infarction, no conclu-
sions can be elucidated in applying this technology to all
patients who present with chest pain.
Clinical implications. These data suggest that the prehos-
pital ECG may be a useful modality for identifying acute
myocardial infarction before hospital arrival and is associated
with the increased usage of reperfusion interventions; short-
ened time to implementation of such therapies once the
patient reaches the hospital; and the greater utilization of
cardiac interventions. The prehospital ECG may represent a
test that can influence the management of the patient with an
acute infarction and have an impact on patients’ hospital
survival. Even with the infrequent utilization of the prehospital
ECG at this time, .75% of patients analyzed in this report
presented to hospitals in communities with prehospital ECG
capability. Although hospitals have an important role in pro-
moting this technology, prehospital emergency medical orga-
nizations have the equally important task of properly training
more emergency personnel, developing greater awareness of
its potential benefits as well as pitfalls and ultimately encour-
aging its wider usage in the community.
Thus, the prehospital ECG is a modality with great poten-
tial for further expansion and may perhaps become a standard
of care for guiding treatment of acute myocardial infarction
among patients who present to the hospital by ambulance.
Despite the favorable outcomes we observed, it should be
pointed out that we cannot fully explain nor entirely rule out
the possibility that the prehospital ECG itself may be associ-
ated with excessive time delay before hospital arrival. Perhaps
with faster implementation and wider usage of the prehospital
ECG, its potential to facilitate the management of acute
myocardial infarction may even be greater. This analysis raises
many important questions as to the future direction of prehos-
pital ECG testing in acute myocardial infarction. Subsequent
studies are needed to investigate the cost/benefit ratio of
universally applying this technology to all patients who present
by ambulance with a chief complaint of chest pain.
We are indebted to Stephen L. Webb, Yuan Zhang, PhD, Joseph M. Hilbe, JD,
PhD, and Lilly Sanathanan, PhD at ClinTrials Research, Inc. for their statistical
expertise.
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